Management

J. Michael Redmond

President & CEO

Mr. Redmond has over 35 years commercial experience in medical device companies. Mr. Redmond held various sales and marketing positions at Abbott Laboratories, a multi-billion-dollar healthcare company. Mr. Redmond then went on to become the Director of Marketing and Business Development at KMC Systems Inc., now a leading private label developer and manufacturer of medical devices and instrumentation. Mr. Redmond helped grow the company from early stage to over $50M in revenue. KMC was sold to Elbit systems. Mr. Redmond then joined Bioject Inc as its VP of Sales and Marketing. Bioject was a medical device company specializing in unique drug delivery technologies. Mr. Redmond helped raise over $15M in capital, entered several licensing and distribution deals with major biotech and pharmaceutical companies growing the market cap of the company from under $10M to over $400M. Mr. Redmond has been CEO of Odyssey Health, Inc. since 2018.

Christine M. Farrell

Chief Financial Officer & Secretary

Christine M. Farrell joined Odyssey in April 2019 as a financial consultant serving as our Controller and Secretary and became Chief Financial Officer and Secretary in January 2021. From February 1997 to 2014, Ms. Farrell was Vice President of Finance for Bioject Medical Technologies Inc., a medical device company specializing in unique drug delivery technologies. Prior to joining Bioject, Ms. Farrell held accounting and financial management positions with Spar-Tek Industries, a manufacturer of high quality and cutting-edge technology for the plywood industry, and Action Machinery, a seller of new and used robotic machine tools and equipment. Ms. Farrell holds a B.A. degree in Accounting from the University of Washington and an M.B.A. from Willamette University in Salem, Oregon.

Greg Gironda

Chief Operating Officer

Greg Gironda has over 30 years of pharmaceutical and biotechnology experience. Greg has held various strategic planning and business development roles at companies like King Pharmaceuticals, Labopharm, EMD Serono, Neura Therapeutik, and Genentech. Greg has built commercial infrastructures and processes for various biopharma companies and has overseen the advancement of multiple pharmaceutical products from conception to commercialization.

Erik Emerson

Chief Commercial Officer

Erik Emerson has 20 plus years of experience in commercial leadership functions within the BioPharmaceutical business. Mr. Emerson has worked in sales, marketing, commercial and business development for organizations that include Mezzion Pharmaceuticals, Adhera therapeutics, XOMA ltd, Gilead Sciences and King Pharmaceuticals. His experience extends from building commercial organizations to extensive fundraising and M&A transactions. Erik is father of 4 and enjoys golf, family and the beach during free time.